Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

biogen_austria_238

Biogen’s Spinraza to go before NICE

January 22, 2018 Sales and Marketing Biogen, Spinraza, biotech, drugs, pharma, pharmaceutical

Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …
News
shutterstock_273326141

Abcam acquires rights to over 700 Roche products in new licensing deal

January 22, 2018 Sales and Marketing Abcam, Roche, partnership, pharma

Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …
News
facilities_lg06

Court fines Dr Reddy’s for improperly packaging products

January 22, 2018 Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …
News
epilim

20,000 left disabled in UK due to sodium valproate use during pregnancy

January 22, 2018 Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma

Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …
News
sanofi_new_paris_hq

Sanofi finally seals big deal with $11.6bn for Bioverativ

January 22, 2018 Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …
News
astrazeneca_sign_sky

AstraZeneca scores double approvals in Japan for asthma and ovarian cancer

January 19, 2018 Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …
News
sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018 Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …
News
pfizer-building-logo1web

Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer

January 19, 2018 Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …
News
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018 Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …
News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
Feature
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018 Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …
News
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018 Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …
News
celgene_1_02

Celgene rumoured to be revving up for Juno buyout

January 17, 2018 Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …
News
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025